Looking Into Vertex Pharmaceuticals's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Vertex Pharmaceuticals (VRTX) has seen a 13.71% decrease in its short percent of float, now at 1.7%. This is lower than its peers' average of 6.15%. The decrease in short interest may indicate a more bullish sentiment towards the stock.
September 18, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Vertex Pharmaceuticals has experienced a 13.71% decrease in short interest, now at 1.7% of float, which is below the peer average of 6.15%. This could indicate a more bullish sentiment towards the stock.
The decrease in short interest suggests that fewer investors are betting against Vertex Pharmaceuticals, which can be interpreted as a sign of increased confidence in the stock. Additionally, the short interest is significantly lower than the peer average, further supporting a potential bullish sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100